QY Research, Inc.

Global Artificial Pancreas Systems Market Will Reach 220 Million US$ by the End of 2025

QY Research has published the new industry research of the “Global Artificial Pancreas Systems market Size and Forecast 2025” The report focuses on Global major leading players with information such as company profiles, product picture, future road map, opportunities and investment.


City of Industry, CA -- (SBWIRE) -- 06/13/2018 -- This report studies the global Artificial Pancreas Systems market status and forecast, categorizes the global Artificial Pancreas Systems market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

Request Sample Copy of the Report @ https://www.qyresearch.com/sample-form/form/152692/global-artificial-pancreas-systems-sales-market

The artificial pancreas is a technology in development to help people with diabetes automatically control their blood glucose level by providing the substitute endocrine functionality of a healthy pancreas.

In terms of application, diabetes type 1 is the biggest downstream consummer in the global artificial pancreas system in 2017, accounting for a more than 90% share. And the revenue form this segement is estimated to see a CAGR of 13.21% from 2017 to 2025.

The global Artificial Pancreas Systems market is valued at 91 million US$ in 2017 and will reach 220 million US$ by the end of 2025, growing at a CAGR of 11.7% during 2018-2025.

Click to view the full report TOC, figure and tables: https://www.qyresearch.com/index/detail/152692/global-artificial-pancreas-systems-sales-market

The major players covered in this report



Tandem Diabetes Care


TypeZero Technologies

Beta Bionics

Johnson & Johnson

Insulet Corp

Bigfoot Biomedical